Medtronic
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 month.
- Recent price momentum is +5.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 1.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 24.6x | Better than 31% |
| Forward P/E | 21.6x | Better than 31% |
| Price / Sales | 3.5x | Better than 35% |
| P/E vs own 5-yr range | 33rd pctl | Better than 74% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.2% | Better than 47% |
| Net income CAGR (3Y) | 8.5% | Better than 56% |
| Free cash flow CAGR (3Y) | 5.8% | Better than 47% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 65.0% | Better than 79% |
| Operating margin | 18.8% | Better than 74% |
| Net margin | 13.2% | Better than 68% |
| Return on equity | 9.8% | Better than 51% |
| Return on invested capital | 7.0% | Better than 55% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 7.1% | Better than 86% |
| 6-month return | 28.3% | Better than 89% |
| 12-month return (ex latest month) | -3.4% | Better than 30% |
| Distance below 52-week high | 5.9% | Better than 93% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.1x | Better than 59% |
| Debt to assets | 30.1% | Better than 41% |
| Interest coverage | 9.6x | Better than 72% |
| Free cash flow / net income | 113.0% | Better than 47% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 60.0% | Better than 36% |
| Upside to average target | 7.3% | Better than 11% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 100.61
- Open
- 101.42
- Day range
- 99.59 - 102.61
- Avg price
- 100.60
- Volume
- 9.03M
- Turnover
- 908.85M
- Turnover ratei
- 0.71%
- Volume ratioi
- 1.48
- Amplitudei
- 3.00%
- 52-week rangei
- 72.06 - 106.20
Valuation
- P/Ei
- 26.79
- P/E (TTM)i
- 24.62
- P/Bi
- 2.54
- EPSi
- 3.73
- Book value / shi
- 39.27
- Net profit
- 4.77B
- Net assets
- 50.23B
Share structure
- Market cap
- 127.84B
- Float capi
- 127.61B
- Shares out
- 1.28B
- Float sharesi
- 1.28B
Dividend & listing
- Div yield (TTM)i
- 2.85%
- Dividend (TTM)
- 2.85
- Listing date
- 1970-01-01
5.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-311.18M net over the window
Short interest
- Shares short
- 22.95M
- % of floati
- 1.79%
- Days to coveri
- 1.86
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Medtronic (MDT)?
Medtronic last traded at 99.94. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Medtronic's market cap?
About 127.84B.
What is the P/E ratio of Medtronic?
The trailing twelve-month P/E is 24.62, below its own 5-year average of 26.59 — toward the bottom of its historical range (32.99% percentile). See the Valuation tab for the full history.
Does Medtronic pay a dividend?
Yes. The trailing dividend yield is 2.85%. The 2025 payout was up 1.4% from 2024. See the Dividends tab for the full payment history.
Is Medtronic a buy according to analysts?
The consensus of 20 analysts is a Buy rating, with an average 12-month price target of 107.24, which implies 7.3% upside from the current price. This is not investment advice.
What is Medtronic's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Medtronic a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.
Medtronic discussion 0 comments